NCT06580340Completed
Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia
Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia:a Prospective Interventional Study
Source: ClinicalTrials.gov · Last updated 27 May 2026
Brief summary (registry, in English)
The present study aims to evaluate the modification of functional capacity induced by an adapted physical activity program in subjects with haemophilia. The exercise program used aims to improve joint mobility, muscle strength, static and dynamic balance, motor coordination. The program is structured in 1 hour sessions of 2 days/week and lasts 6 months. The primary endpoint is the change in functional capacity calculated as the difference between the baseline assessment and the 3 and 6 month assessment of the 6 Minutes Walking Test measured with the G-Walk (BTS Bioengineering S.p.A).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 23 Aug 2024
- Start date
- 10 Sept 2024
- Primary completion date
- 27 Oct 2025
- Lead sponsor
- Istituto Ortopedico Rizzoli
- Diseases
- Haemophilia
- NCT number
- NCT06580340
What you commit to
- Study type: Interventional
- Participants enrolled: 14
- From 10 Sept 2024 to the primary completion date, 27 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Myocardial infarction or hospitalization within the previous 6 months
Other illness
- Active bleeding
- Insufficiency of communicative and/or sensory functions so severe that it is impossible to understand or carry out the trainer's instructions (dementia, aphasia, blindness, deafness)
- Heart failure (NYHA class \> 2)
- Unstable angina
- Lung disease requiring oxygen therapy
- Symptomatic peripheral arterial disease
- Hypertension in poor pharmacological control (diastolic\> 95 mmHg, systolic\> 160 mmHg)
- Significant neurological conditions that impair motor or cognitive function
Other
- Severe joint deformities that prevent exercise
- Symptomatic orthostatic hypotension
Who the study is looking for
- Diagnosis of hemophilia A or B;
- Signature of informed consent;
- Availability of a medical certificate for non-competitive activities
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istituto Ortopedico Rizzoli Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.